Mini review: Current status and perspective of S100B protein as a biomarker in daily clinical practice for diagnosis and prognosticating of clinical outcome in patients …
T Abboud, V Rohde, D Mielke - BMC neuroscience, 2023 - Springer
Prognosticating the clinical outcome of neurological diseases is essential to guide treatment
and facilitate decision-making. It usually depends on clinical and radiological findings …
and facilitate decision-making. It usually depends on clinical and radiological findings …
Definition, prediction, prevention and management of patients with severe ischemic stroke and large infarction
X Hua, M Liu, S Wu - Chinese Medical Journal, 2023 - mednexus.org
Severe ischemic stroke carries a high rate of disability and death. The severity of stroke is
often assessed by the degree of neurological deficits or the extent of brain infarct, defined as …
often assessed by the degree of neurological deficits or the extent of brain infarct, defined as …
Use of biomarkers for predicting a malignant course in acute ischemic stroke: an observational case–control study
A Guimarães de Almeida Barros, L Roquim e Silva… - Scientific Reports, 2023 - nature.com
Acute ischemic stroke is a sudden neurological event caused by brain ischemia. Patients
with large vessel occlusion are at high risk of developing significant cerebral edema, which …
with large vessel occlusion are at high risk of developing significant cerebral edema, which …
[HTML][HTML] Current Trends in Stroke Biomarkers: The Prognostic Role of S100 Calcium-Binding Protein B and Glial Fibrillary Acidic Protein
G Anogianakis, S Daios, N Topouzis… - Life, 2024 - mdpi.com
Stroke is the third leading cause of death in the developed world and a major cause of
chronic disability, especially among the elderly population. The major biomarkers of stroke …
chronic disability, especially among the elderly population. The major biomarkers of stroke …
The role of blood protein biomarkers in acute ischemic stroke prognosis
A Sabbah, M Elsayed, H Helmy, RH Mostafa… - The Egyptian Journal of …, 2024 - Springer
Background Stroke is one of the most frequent causes of mortality and disability, blood
protein biomarkers are used to determine patients at high risk for a severe illness and to …
protein biomarkers are used to determine patients at high risk for a severe illness and to …
Ginkgo biloba active compounds can modulate the development of acute mountain sickness and ischemic stroke as discovered by network pharmacology and …
H Guo, X Kang, Y Xu, C Wang, C Wang - iLABMED, 2024 - Wiley Online Library
Background A combination of molecular docking, molecular dynamics simulations, and
herbal network pharmacology was used to investigate the shared key targets and potential …
herbal network pharmacology was used to investigate the shared key targets and potential …
缺血性脑卒中脑水肿研究进展.
陈红, 郑小红, 苏湲淇, 徐晓玉… - Journal of Modern …, 2024 - search.ebscohost.com
缺血性脑卒中脑水肿是缺血性脑卒中后脑损伤的重要因素. 目前, 对缺血性脑卒中脑水肿的深
层次机制了解还不够充分, 已有的机制复杂且处于动态变化中, 临床上尚缺乏普遍有效的预防和 …
层次机制了解还不够充分, 已有的机制复杂且处于动态变化中, 临床上尚缺乏普遍有效的预防和 …
[PDF][PDF] REVIEW Open Access
T Abboud, V Rohde, D Mielke - 2023 - bmcneurosci.biomedcentral.com
Prognosticating the clinical outcome of neurological diseases is essential to guide treatment
and facilitate decisionmaking. It usually depends on clinical and radiological findings …
and facilitate decisionmaking. It usually depends on clinical and radiological findings …